These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3708680)

  • 21. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind clinical comparison of the electrophysiologic adverse effects of Hexabrix and Renografin-76.
    Wolf GL
    Invest Radiol; 1984; 19(6 Suppl):S328-32. PubMed ID: 6392161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of Hexabrix and Renografin 60 in peripheral arteriography.
    Sacks BA; Ellison HP; Bartek S; Vine HS; Palestrant AM
    Invest Radiol; 1984; 19(6 Suppl):S320-2. PubMed ID: 6392159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contrast injection bradycardia during coronary angiography: effects in the denervated human heart.
    Mukharji J; Thames MD; Newton M; Hirsh PD; Lewis SA; Rehr RB; Cowley MJ; Hess ML; Hastillo A; Lower RR
    J Heart Transplant; 1987; 6(1):44-8. PubMed ID: 3302186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in platelet activity and tissue plasminogen activator during arteriography in patients with chronic limb ischaemia.
    Polanowska R; Wilczyńska M; Sławiński W; Goch JH; Augustyniak W; Cierniewski CS
    Thromb Res; 1992 Mar; 65(4-5):663-5. PubMed ID: 1535464
    [No Abstract]   [Full Text] [Related]  

  • 26. Ventricular fibrillation during coronary angiography: reduced incidence with nonionic contrast media.
    Missri J; Jeresaty RM
    Cathet Cardiovasc Diagn; 1990 Jan; 19(1):4-7. PubMed ID: 2306765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary arteriography: comparison of cough stimulation effects of diatrizoate and ioxaglate.
    Smith DC; Lois JF; Gomes AS; Maloney MD; Yahiku PY
    Radiology; 1987 Mar; 162(3):617-8. PubMed ID: 3544028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
    Makkar RR; Fromm BS; Steinman RT; Meissner MD; Lehmann MH
    JAMA; 1993 Dec; 270(21):2590-7. PubMed ID: 8230644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pause-dependent torsade de pointes following acute myocardial infarction: a variant of the acquired long QT syndrome.
    Halkin A; Roth A; Lurie I; Fish R; Belhassen B; Viskin S
    J Am Coll Cardiol; 2001 Oct; 38(4):1168-74. PubMed ID: 11583899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The comparative effects of ionic versus nonionic agents in cardiac catheterization.
    Benotti JR
    Invest Radiol; 1988 Nov; 23 Suppl 2():S366-73. PubMed ID: 3058641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial contrast echocardiography in humans: I. Safety--a comparison with routine coronary arteriography.
    Moore CA; Smucker ML; Kaul S
    J Am Coll Cardiol; 1986 Nov; 8(5):1066-72. PubMed ID: 3760381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent severe reaction to iodinated contrast media during cardiac catheterization.
    Slack JD; Slack LA; Orr C
    Heart Lung; 1982; 11(4):348-52. PubMed ID: 6919532
    [No Abstract]   [Full Text] [Related]  

  • 33. Angiographic contrast agent-induced acute hemolysis in a patient with hemoglobin SC disease.
    Rao AK; Thompson R; Durlacher L; James F
    Arch Intern Med; 1985 Apr; 145(4):759-60. PubMed ID: 3985742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent torsade de pointes type ventricular tachycardia in intracranial hemorrhage.
    Sen S; Stober T; Burger L; Anstätt T; Rettig G
    Intensive Care Med; 1984; 10(5):263-4. PubMed ID: 6491039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse effects of calcium binding contrast agents in diagnostic cardiac angiography. A comparison between formulations with and without calcium binding additives.
    Matthai WH; Groh WC; Waxman HL; Kurnik PB
    Invest Radiol; 1995 Nov; 30(11):663-8. PubMed ID: 8557507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular radiology. The fibrillatory propensities of contrast agents.
    Wolf GL
    Invest Radiol; 1980; 15(6 Suppl):S208-14. PubMed ID: 7203925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of fibrillation with isotonic contrast media for intra-arterial coronary digital subtraction angiography.
    Morris TW; Hayakawa K; Sahler LG; Ekholm S
    Diagn Imaging Clin Med; 1986; 55(3):109-13. PubMed ID: 3522039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic and electrocardiographic effects in man of a new nonionic contrast agent (iohexol): advantages over standard ionic agents.
    Mancini GB; Bloomquist JN; Bhargava V; Stein JB; Lew W; Slutsky RA; Shabetai R; Higgins CB
    Am J Cardiol; 1983 Apr; 51(7):1218-22. PubMed ID: 6837464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical superiority of a new nonionic contrast agent (iopamidol) for cardiac angiography.
    Gertz EW; Wisneski JA; Chiu D; Akin JR; Hu C
    J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):250-8. PubMed ID: 3881496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osmotic disruption of the blood-ocular barriers.
    Li V; Turski PA; Levin AB; Weinstein J; Rozental J; Strother CM
    AJNR Am J Neuroradiol; 1987; 8(2):347-8. PubMed ID: 3105289
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.